Is tesamorelin the same as Egrifta?
Yes, as a name. Egrifta is a brand name for tesamorelin, the longer-lasting GHRH copy this site's profile lists as another name. Egrifta is the FDA approved product for HIV-related deep belly fat. In 412 people at 26 weeks, deep belly fat fell 15.2%, while it rose 5.0% on a dummy shot. Across both large final-stage studies, 806 people pooled, the drug cut deep belly fat by 15.4% more than the dummy shot, with no change in the fat just under the skin. A research-chemical vial labeled tesamorelin is not that approved product. The molecule can share the name. The labeled medicine is not the same product.
Studies in people from the compound pages this answer belongs to
- Tesamorelin
- Metabolic effects of a growth hormone-releasing factor in patients with HIV 2007 PMID 18057338
- Effects of tesamorelin (TH9507) in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data 2010 PMID 20554713
- Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial 2012 PMID 22869065
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of further names and published absences. Leftover harvested questions after the first two absence sets: more brand versus molecule names, side effects the citations did not count, compounding formulas this catalogue does not hold, national FDA and Australia fields, trial windows rather than an onset clock, named combinations with no interaction table, and oral routes that have not been studied.